| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/18/1997 | EP0512017B1 Vaccines |
| 06/18/1997 | CN1152311A Anti-helicobacter acyl derivatives of azolones |
| 06/18/1997 | CN1152310A Anti-helicobacter heterocyclic derivatives of azolines |
| 06/18/1997 | CN1152309A Anti-helicobacter urea and thiourea derivatives of azolones |
| 06/18/1997 | CN1152308A Sulfonamide derivatives of azolones anti-helicobacter agents |
| 06/18/1997 | CN1151889A Fengmu ointment series |
| 06/18/1997 | CN1035181C Process for prep. of 3-unsaturated alkyl cephems from 3-triflyl cepheme |
| 06/17/1997 | US5639882 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
| 06/17/1997 | US5639873 Oligothionucleotides |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639854 Amino acid sequence of a t-cell epitope of the gag protein of hiv-1; vaccines |
| 06/17/1997 | US5639852 Analogs of cyclosporin a |
| 06/17/1997 | US5639769 Administering antiviral agent |
| 06/17/1997 | US5639755 Methods of combatting infectious diseases using dicationic bis-benzimidazoles |
| 06/17/1997 | US5639754 Bactericides treating helicobacter infection |
| 06/17/1997 | US5639742 Antibiotic; bactericide |
| 06/17/1997 | US5639735 Antitumor antibiotic compounds: hayumicins and analogs thereof |
| 06/17/1997 | US5639712 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
| 06/17/1997 | US5639650 cDNA clone for South African Arbovirus No. 86 |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639595 Identification of novel drugs and reagents |
| 06/17/1997 | US5639594 Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
| 06/17/1997 | US5639453 Therapeutic uses of IL-3 |
| 06/17/1997 | US5639452 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997021103A1 Treatment and diagnosis of infections due to helicobacter pylori |
| 06/12/1997 | WO1997021100A1 Hiv protease inhibitors |
| 06/12/1997 | WO1997020934A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020857A1 Cyclic dodecapeptide and process for the preparation thereof |
| 06/12/1997 | WO1997020844A1 β-METHYLCARBAPENEM DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME |
| 06/12/1997 | WO1997020842A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 06/12/1997 | WO1997020839A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020560A1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 06/12/1997 | WO1997020559A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 06/12/1997 | WO1997020554A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 06/12/1997 | WO1997020468A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 06/12/1997 | WO1997011667A3 Therapeutic applications using horse serum |
| 06/12/1997 | DE19545463A1 Organisch-chemische Verbindung und Verfahren zu ihrer Herstellung Organic chemical compound and processes for their preparation |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239728A1 Live attenuated vaccines based on cp45 hpiv-3 strain and method to ensure attenuation in such vaccines |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239409A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238471A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 06/12/1997 | CA2238337A1 Hiv protease inhibitors |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778283A2 Antibiotic macrolides |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778271A2 Aminoalkyl-substituted benzo-heterocyclic compounds |
| 06/11/1997 | EP0778264A1 Tertiary amines having antimycotic and cholesterol lowering activity |
| 06/11/1997 | EP0778026A1 Remedy for endotoxinemia and multiple organ failure induced thereby |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0778022A1 Treatment of chlamydia infectious diseases by rifamycin derivative |
| 06/11/1997 | EP0777733A1 Method of treating birds with avian myelomonocytic growth factor |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777685A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 06/11/1997 | EP0777673A2 Alpha-d-pentofuranoside derivatives, process for preparing the same and their use |
| 06/11/1997 | EP0777669A1 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
| 06/11/1997 | EP0777653A1 Dihygropyridine derivatives as bradykinin antagonists |
| 06/11/1997 | EP0777644A1 D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof |
| 06/11/1997 | EP0777497A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777490A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 06/11/1997 | EP0777457A1 Use of glyceryl triacetate for treating onychomycoses |
| 06/11/1997 | EP0746320A4 Hiv protease inhibitors and intermediates |
| 06/11/1997 | EP0662964B1 Heterocyclic amines having calmodulin antagonist properties |
| 06/11/1997 | EP0472706B1 Induction of protection against viral infection |
| 06/11/1997 | CN1151746A Novel erythromycin derivatives, method for their preparation and their use as drugs |
| 06/11/1997 | CN1151697A Anti-hiv triple combination |
| 06/11/1997 | CN1151696A 抗菌剂 Antibacterial agents |
| 06/10/1997 | US5637721 Process for the preparation of cephem prodrug esters |
| 06/10/1997 | US5637711 Chemical intermediate; 1-epoxidemethyl substituted piperazine ring |
| 06/10/1997 | US5637707 2-substituted tertiary carbinol derivatives of 1, 5-iminosugars |
| 06/10/1997 | US5637691 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
| 06/10/1997 | US5637690 Sulfate of n-acetylneuraminic acid homopolymer and processes for making and using the same |
| 06/10/1997 | US5637684 Phosphoramidate and phosphorothioamidate oligomeric compounds |
| 06/10/1997 | US5637612 Mixture with dipeptidase inhibitor |
| 06/10/1997 | US5637592 Treating helicobacter infections, such as gastritis, stomach ulcers, duodenal ulcers and gastric cancer |
| 06/10/1997 | US5637591 Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide and derivatives |
| 06/10/1997 | US5637590 Rapamycin amidino carbamates |
| 06/10/1997 | US5637581 Preparations containing 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines |
| 06/10/1997 | US5637580 Antimicrobial penem-quinolones |
| 06/10/1997 | US5637579 Beta-lactamase inhibitors; bactericides |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637576 Administering oligosaccharide sequence covalently attached to solid support |
| 06/10/1997 | US5637574 Therapeutic nucleosides |
| 06/10/1997 | US5637565 Cocrystallization of different streptogramins |
| 06/10/1997 | US5637288 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 06/09/1997 | CA2190708A1 Aminoalkyl substituted benzo-heterocyclic compounds |
| 06/09/1997 | CA2190699A1 Tertiary amines |
| 06/05/1997 | WO1997020059A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |